The rights we now have in CT are threatened by Project 2025’s plan to push the FDA to reverse approval of mifepristone and misoprostol.
The rights we now have in CT are threatened by Project 2025’s plan to push the FDA to reverse approval of mifepristone and misoprostol.
Our trusted Connecticut public policy reporting is always free to read. Get it directly in your inbox every morning.
You'll get newsletter-exclusive insights and commentary so you can be part of the conversation.
